VBIV logo

VBI Vaccines (VBIV) Cash From Financing

Annual CFF

$22.70 M
+$3.25 M+16.71%

December 31, 2023

Summary

Performance

1-Year Change

+16.71%

3-Year Change

-81.45%

5-Year Change

-47.96%

15-Year Change

-66.24%

VBIV Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$122.39 M
VBIV annual cash flow from financing activities is currently -81.45% below its historical high of $122.39 million

3-Year Low

$19.45 M
VBIV annual cash flow from financing activities is currently +16.71% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VBIV previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
VBIV next annual earnings announcement has not yet been scheduled

OtherVBIVcash flowmetrics:

Annual CFI

-$867.00 K
VBIV annual cash flow from investing activities is -$867.00 thousand

Annual CFO

-$60.88 M
VBIV annual cash flow from operations is -$60.88 million

Annual FCF

-$61.75 M
VBIV annual free cash flow is -$61.75 million

Annual CAPEX

$867.00 K
VBIV annual capital expenditures is $867.00 thousand

Quarterly CFF

$843.00 K
+$571.00 K+209.93%

March 31, 2024

Summary

Performance

3-Month Change

+209.93%

1-Year Change

+100%

3-Year Change

+100%

5-Year Change

+100%

VBIV Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$67.22 M
VBIV quarterly cash flow from financing activities is currently -98.75% below its historical high of $67.22 million

3-Year Low

$0.00
VBIV quarterly cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
VBIV previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
VBIV next earnings announcement has not yet been scheduled

OtherVBIVcash flowmetrics:

Quarterly CFI

-$151.00 K
VBIV quarterly cash flow from investing activities is -$151.00 thousand

Quarterly CFO

-$11.77 M
VBIV quarterly cash flow from operations is -$11.77 million

Quarterly FCF

-$11.92 M
VBIV quarterly free cash flow is -$11.92 million

Quarterly CAPEX

$151.00 K
VBIV quarterly capital expenditures is $151.00 thousand

TTM CFF

$23.54 M
+$843.00 K+3.71%

March 31, 2024

Summary

Performance

3-Month Change

+3.71%

1-Year Change

+21.11%

3-Year Change

+21.04%

5-Year Change

+21.04%

VBIV TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$144.62 M
VBIV TTM cash flow from financing activities is currently -83.72% below its historical high of $144.62 million

3-Year Low

$9.96 M
VBIV TTM cash flow from financing activities is currently +136.38% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
VBIV previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
VBIV next earnings announcement has not yet been scheduled

OtherVBIVcash flowmetrics:

TTM CFI

-$484.00 K
VBIV TTM cash flow from investing activities is -$484.00 thousand

TTM CFO

-$51.00 M
VBIV TTM cash flow from operations is -$51.00 million

TTM FCF

-$51.48 M
VBIV TTM free cash flow is -$51.48 million

TTM CAPEX

$484.00 K
VBIV TTM capital expenditures is $484.00 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

VBIV Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.7%+100.0%+21.1%
3 y3 years-81.5%+100.0%+21.0%
5 y5 years-48.0%+100.0%+21.0%

VBIV Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-48.8%-14.3%-96.2%-100.0%-46.9%-57.7%
5 y5-year-81.5%-14.3%-98.6%-171.2%-83.7%-57.7%
alltimeall time-81.5%-100.0%-98.7%-429.3%-83.7%-100.8%

VBI Vaccines Cash From Financing History

DateAnnualQuarterlyTTM
Mar 2024
-
$843.00 K(+209.9%)
$23.54 M(+3.7%)
Dec 2023
$22.70 M(+16.7%)
$272.00 K(-98.8%)
$22.70 M(+1.2%)
Sep 2023
-
$22.43 M(>+9900.0%)
$22.43 M(+15.4%)
Jun 2023
-
$0.00(0.0%)
$19.44 M(0.0%)
Mar 2023
-
$0.00(0.0%)
$19.44 M(-0.1%)
Dec 2022
$19.45 M(-56.1%)
$0.00(-100.0%)
$19.45 M(-12.9%)
Sep 2022
-
$19.44 M(>+9900.0%)
$22.34 M(+124.3%)
Jun 2022
-
$0.00(-100.0%)
$9.96 M(-56.1%)
Mar 2022
-
$12.00 K(-99.6%)
$22.68 M(-48.8%)
Dec 2021
$44.29 M(-63.8%)
$2.89 M(-59.0%)
$44.29 M(-22.2%)
Sep 2021
-
$7.05 M(-44.5%)
$56.93 M(-42.6%)
Jun 2021
-
$12.72 M(-41.2%)
$99.17 M(-31.4%)
Mar 2021
-
$21.62 M(+39.3%)
$144.62 M(+18.2%)
Dec 2020
$122.39 M(+227.1%)
$15.53 M(-68.5%)
$122.39 M(+14.6%)
Sep 2020
-
$49.29 M(-15.3%)
$106.79 M(+12.4%)
Jun 2020
-
$58.17 M(-9795.5%)
$94.99 M(+158.0%)
Mar 2020
-
-$600.00 K(+659.5%)
$36.81 M(-1.6%)
Dec 2019
$37.41 M(-14.2%)
-$79.00 K(-100.2%)
$37.41 M(-53.8%)
Sep 2019
-
$37.49 M(>+9900.0%)
$81.05 M(+86.1%)
Jun 2019
-
$0.00(0.0%)
$43.55 M(-0.1%)
Mar 2019
-
$0.00(-100.0%)
$43.61 M(-0.0%)
Dec 2018
$43.62 M(-35.1%)
$43.55 M(>+9900.0%)
$43.62 M(-35.2%)
Sep 2018
-
$0.00(-100.0%)
$67.29 M(0.0%)
Jun 2018
-
$60.00 K(+1100.0%)
$67.29 M(+0.1%)
Mar 2018
-
$5000.00(-100.0%)
$67.23 M(-0.0%)
Dec 2017
$67.24 M(+84.3%)
$67.22 M(>+9900.0%)
$67.24 M(+189.0%)
Sep 2017
-
$0.00(0.0%)
$23.26 M(+1.0%)
Jun 2017
-
$0.00(-100.0%)
$23.04 M(-36.9%)
Mar 2017
-
$16.00 K(-99.9%)
$36.50 M(+0.0%)
Dec 2016
$36.48 M(+6533.3%)
$23.25 M(<-9900.0%)
$36.48 M(+175.7%)
Sep 2016
-
-$225.00 K(-101.7%)
$13.23 M(-1.7%)
Jun 2016
-
$13.46 M(>+9900.0%)
$13.46 M(>+9900.0%)
Mar 2016
-
$0.00(-100.0%)
$32.60 K(-99.4%)
Dec 2015
$550.00 K(-90.1%)
-
-
Jun 2015
-
$32.60 K(-106.4%)
$5.55 M(-0.3%)
Mar 2015
-
-$512.60 K(-108.5%)
$5.56 M(-8.4%)
Mar 2015
$5.56 M(>+9900.0%)
-
-
Dec 2014
-
$6.03 M(<-9900.0%)
$6.08 M(>+9900.0%)
Sep 2014
-
-$2100.00(-104.5%)
$44.80 K(-4.5%)
Jun 2014
-
$46.90 K(>+9900.0%)
$46.90 K(>+9900.0%)
Mar 2014
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Dec 2013
-
$0.00(0.0%)
$6500.00(+4.8%)
Sep 2013
-
$0.00(0.0%)
$6200.00(-82.0%)
Jun 2013
-
$0.00(-100.0%)
$34.40 K(0.0%)
Mar 2013
$34.40 K(-99.9%)
$6500.00(-2266.7%)
$34.40 K(-98.2%)
Dec 2012
-
-$300.00(-101.1%)
$1.93 M(-32.0%)
Sep 2012
-
$28.20 K(>+9900.0%)
$2.84 M(+8957.8%)
Jun 2012
-
$0.00(-100.0%)
$31.30 K(-99.9%)
Mar 2012
$52.77 M
$1.90 M(+109.4%)
$52.77 M(+0.2%)
Dec 2011
-
$907.30 K(-132.7%)
$52.69 M(-2.4%)
Sep 2011
-
-$2.78 M(-105.3%)
$53.97 M(-19.9%)
DateAnnualQuarterlyTTM
Jun 2011
-
$52.74 M(+2797.3%)
$67.34 M(+356.8%)
Mar 2011
$14.74 M(+283.9%)
$1.82 M(-16.9%)
$14.74 M(+10.2%)
Dec 2010
-
$2.19 M(-79.3%)
$13.38 M(-3.5%)
Sep 2010
-
$10.60 M(+7785.2%)
$13.87 M(+248.9%)
Jun 2010
-
$134.40 K(-70.6%)
$3.97 M(+3.5%)
Mar 2010
$3.84 M(+1074.0%)
$457.40 K(-82.9%)
$3.84 M(+7.4%)
Dec 2009
-
$2.68 M(+280.6%)
$3.57 M(+308.5%)
Sep 2009
-
$703.80 K(>+9900.0%)
$875.00 K(+430.3%)
Jun 2009
-
$0.00(-100.0%)
$165.00 K(-49.6%)
Mar 2009
$327.10 K(-19.4%)
$191.50 K(-1043.3%)
$327.10 K(+173.5%)
Dec 2008
-
-$20.30 K(+227.4%)
$119.60 K(-47.2%)
Sep 2008
-
-$6200.00(-103.8%)
$226.60 K(-15.8%)
Jun 2008
-
$162.10 K(-1113.1%)
$269.00 K(-33.7%)
Mar 2008
$405.60 K(-29.4%)
-$16.00 K(-118.5%)
$405.60 K(-42.6%)
Dec 2007
-
$86.70 K(+139.5%)
$706.80 K(-10.9%)
Sep 2007
-
$36.20 K(-87.9%)
$793.40 K(+4.6%)
Jun 2007
-
$298.70 K(+4.7%)
$758.50 K(+32.0%)
Mar 2007
$574.70 K(-30.1%)
$285.20 K(+64.6%)
$574.60 K(-40.3%)
Dec 2006
-
$173.30 K(>+9900.0%)
$962.60 K(+2.6%)
Sep 2006
-
$1300.00(-98.9%)
$937.80 K(+0.1%)
Jun 2006
-
$114.80 K(-82.9%)
$936.50 K(+14.0%)
Mar 2006
$821.70 K(+100.9%)
$673.20 K(+353.3%)
$821.70 K(+866.7%)
Dec 2005
-
$148.50 K(>+9900.0%)
$85.00 K(+2831.0%)
Sep 2005
-
$0.00(0.0%)
$2900.00(-96.9%)
Jun 2005
-
$0.00(-100.0%)
$94.50 K(-76.9%)
Mar 2005
$409.10 K(-11.0%)
-$63.50 K(-195.6%)
$409.10 K(-42.3%)
Dec 2004
-
$66.40 K(-27.5%)
$709.10 K(-18.1%)
Sep 2004
-
$91.60 K(-70.9%)
$865.90 K(+11.8%)
Jun 2004
-
$314.60 K(+33.0%)
$774.30 K(+68.4%)
Mar 2004
$459.80 K(+328.5%)
$236.50 K(+6.0%)
$459.70 K(+39.1%)
Dec 2003
-
$223.20 K(>+9900.0%)
$330.50 K(+208.0%)
Sep 2003
-
$0.00(0.0%)
$107.30 K(0.0%)
Jun 2003
-
$0.00(-100.0%)
$107.30 K(0.0%)
Mar 2003
$107.30 K(>+9900.0%)
$107.30 K(>+9900.0%)
$107.30 K(>+9900.0%)
Dec 2002
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2002
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2002
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2002
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Dec 2001
-
$0.00(0.0%)
-$8100.00(-94.4%)
Sep 2001
-
$0.00(0.0%)
-$144.40 K(-19.3%)
Jun 2001
-
$0.00(-100.0%)
-$179.00 K(-212.9%)
Mar 2001
$158.60 K(>+9900.0%)
-$8100.00(-94.1%)
$158.60 K(-4.9%)
Dec 2000
-
-$136.30 K(+293.9%)
$166.70 K(-45.0%)
Sep 2000
-
-$34.60 K(-110.2%)
$303.00 K(-10.2%)
Jun 2000
-
$337.60 K(>+9900.0%)
$337.60 K(>+9900.0%)
Mar 2000
$0.00(0.0%)
-
-
Mar 1999
$0.00(0.0%)
-
-
Mar 1998
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Dec 1997
-
$0.00(0.0%)
$0.00(0.0%)
Sep 1997
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1997
-
$0.00
$0.00
Mar 1997
$434.80 K
-
-

FAQ

  • What is VBI Vaccines annual cash flow from financing activities?
  • What is the all time high annual CFF for VBI Vaccines?
  • What is VBI Vaccines annual CFF year-on-year change?
  • What is VBI Vaccines quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for VBI Vaccines?
  • What is VBI Vaccines quarterly CFF year-on-year change?
  • What is VBI Vaccines TTM cash flow from financing activities?
  • What is the all time high TTM CFF for VBI Vaccines?
  • What is VBI Vaccines TTM CFF year-on-year change?

What is VBI Vaccines annual cash flow from financing activities?

The current annual CFF of VBIV is $22.70 M

What is the all time high annual CFF for VBI Vaccines?

VBI Vaccines all-time high annual cash flow from financing activities is $122.39 M

What is VBI Vaccines annual CFF year-on-year change?

Over the past year, VBIV annual cash flow from financing activities has changed by +$3.25 M (+16.71%)

What is VBI Vaccines quarterly cash flow from financing activities?

The current quarterly CFF of VBIV is $843.00 K

What is the all time high quarterly CFF for VBI Vaccines?

VBI Vaccines all-time high quarterly cash flow from financing activities is $67.22 M

What is VBI Vaccines quarterly CFF year-on-year change?

Over the past year, VBIV quarterly cash flow from financing activities has changed by +$843.00 K (+100.00%)

What is VBI Vaccines TTM cash flow from financing activities?

The current TTM CFF of VBIV is $23.54 M

What is the all time high TTM CFF for VBI Vaccines?

VBI Vaccines all-time high TTM cash flow from financing activities is $144.62 M

What is VBI Vaccines TTM CFF year-on-year change?

Over the past year, VBIV TTM cash flow from financing activities has changed by +$4.10 M (+21.11%)